How Much Is Skyrizi With Insurance? | Cost Breakdown Guide

Skyrizi typically costs $5,000 to $6,000 per dose, but insurance coverage and assistance programs can significantly reduce out-of-pocket expenses.

Understanding Skyrizi and Its Pricing Structure

Skyrizi (risankizumab) is a prescription medication primarily used to treat moderate to severe plaque psoriasis and psoriatic arthritis. It belongs to a class of drugs known as biologics, which target specific parts of the immune system to reduce inflammation and skin symptoms. Biologics like Skyrizi are complex molecules produced through biotechnology, which contributes to their high manufacturing costs.

The list price for Skyrizi is substantial—each dose can cost between $5,000 and $6,000. Since the treatment involves multiple doses throughout the year, annual costs may easily exceed $50,000 without insurance. This steep price tag often raises concerns for patients considering or currently using this medication.

However, insurance coverage plays a pivotal role in determining how much patients actually pay. Health plans vary widely in their coverage policies for biologics, copay requirements, deductibles, and prior authorization rules. Understanding the nuances of insurance coverage is essential to estimate your real cost for Skyrizi.

How Insurance Affects the Cost of Skyrizi

Insurance companies negotiate prices with drug manufacturers and pharmacies, which can drastically lower the amount patients pay at the pharmacy counter. The extent of coverage depends on several factors:

    • Type of Insurance Plan: Employer-sponsored plans, Medicare Part D, Medicaid, and marketplace plans all handle biologic drug coverage differently.
    • Formulary Placement: Skyrizi’s placement on your insurer’s formulary (preferred drug list) affects copays and prior authorization requirements.
    • Deductible Status: If your deductible hasn’t been met for the year, you might pay more upfront until it’s satisfied.
    • Copayments or Coinsurance: Some plans require fixed copays per prescription; others charge coinsurance—a percentage of the drug cost.

For example, a patient with commercial insurance might pay a copay ranging from $30 to $150 per dose after meeting their deductible. Conversely, someone with Medicare Part D could face higher coinsurance rates depending on their plan’s tier system.

Prior Authorization and Step Therapy Requirements

Many insurers require prior authorization before approving Skyrizi coverage. This means your healthcare provider must submit documentation proving that Skyrizi is medically necessary—often after trying other treatments first.

Step therapy protocols may require patients to try less expensive drugs before moving on to biologics like Skyrizi. These hurdles can delay access but also affect out-of-pocket costs if alternative treatments are covered differently.

Patient Assistance Programs That Lower Costs

Given the high price of Skyrizi even with insurance, manufacturer-sponsored assistance programs exist to ease financial burdens:

    • Copay Cards: For commercially insured patients, AbbVie (the maker of Skyrizi) offers copay cards that can reduce monthly copays to as low as $5 or even zero in some cases.
    • Patient Savings Programs: These programs may cap out-of-pocket expenses annually or provide discounts on treatment.
    • Financial Assistance for Uninsured: AbbVie also offers support for uninsured or underinsured patients through grants or free medication programs based on income eligibility.

These resources often require enrollment and proof of eligibility but can make a world of difference in affordability.

The Role of Specialty Pharmacies

Skyrizi is typically dispensed via specialty pharmacies that specialize in handling complex medications requiring refrigeration and patient education. Specialty pharmacies often work closely with insurers and patient assistance programs to coordinate benefits and minimize costs.

They may also offer adherence support services that help patients stay on track with dosing schedules—important since consistent use maximizes effectiveness.

A Detailed Look: Average Costs With Insurance Coverage

To better visualize how insurance impacts pricing for Skyrizi, here’s a breakdown table showing typical patient out-of-pocket costs based on different insurance scenarios:

Insurance Type Estimated Patient Cost Per Dose Notes
Commercial Insurance + Copay Card $5 – $50 Copay card reduces copay significantly; deductible usually met
Commercial Insurance Without Copay Card $150 – $300+ No financial assistance; coinsurance may apply; deductible status varies
Medicare Part D Plan $200 – $600+ Coinsurance applies; coverage gap (“donut hole”) may increase costs temporarily
No Insurance / Uninsured Patient Assistance Program $0 – $100* *Based on income eligibility; application required for free or discounted meds

These figures are averages drawn from various patient reports and insurer data but individual experiences will vary widely depending on specific plan details.

The Impact of Dosage Frequency on Overall Cost

Skyrizi dosing starts with two initial injections four weeks apart followed by maintenance doses every 12 weeks. This schedule means fewer doses annually compared to some other biologics dosed every two or four weeks.

While each dose carries a high price tag upfront, this extended dosing interval can lower total yearly medication costs relative to more frequent injections. Patients should consider both per-dose cost and annual usage when evaluating affordability.

Dosing Schedule Breakdown:

    • Initial Phase: Two injections at week 0 and week 4.
    • Maintenance Phase: One injection every 12 weeks thereafter.

This regimen results in about five doses per year after initiation—significantly fewer than many alternatives requiring monthly dosing.

The Role of Healthcare Providers in Navigating Costs

Doctors and dermatologists often play an essential role in helping patients navigate insurance complexities related to Skyrizi. They can:

    • Submit Prior Authorizations: Ensuring timely approval from insurers by providing necessary medical documentation.
    • Select Appropriate Treatment Plans: Considering patient budget constraints alongside clinical efficacy when recommending therapies.
    • Liaise With Specialty Pharmacies: Coordinating medication delivery and assistance program enrollment.
    • Elicit Patient Concerns About Affordability: Opening dialogue about financial barriers so solutions can be explored proactively.

Proactive communication between patients and providers helps minimize delays in treatment initiation due to cost issues.

Navigating Pharmacy Benefit Managers (PBMs) Influence On Cost

Pharmacy Benefit Managers are intermediaries that negotiate drug prices between manufacturers and insurers. Their role affects how much insurers pay—and ultimately what patients owe—for medications like Skyrizi.

PBMs determine formulary placement (which drugs are preferred), set tier levels influencing copays/coinsurance rates, and manage rebate agreements that impact list prices indirectly. Understanding PBM influence clarifies why some plans favor certain biologics over others or impose stricter utilization controls.

While PBMs aim to reduce overall drug spending for insurers, their negotiations sometimes lead to higher out-of-pocket costs for patients depending on plan design.

The Importance of Reviewing Your Insurance Plan Annually

Insurance benefits change yearly during open enrollment periods. Copays, deductibles, formularies, and prior authorization policies may shift dramatically impacting what you pay for medications like Skyrizi.

It pays off to review your plan details annually:

    • Check if Skyrizi remains covered at the same tier level.
    • Avoid surprise increases in coinsurance percentages or deductibles.
    • If switching plans is an option, compare expected out-of-pocket expenses specifically for your medications.
    • Avoid gaps in coverage that could delay treatment access or increase upfront costs.

Staying informed helps you avoid unexpected financial strain mid-year.

Taking Control: How Much Is Skyrizi With Insurance?

The question “How Much Is Skyrizi With Insurance?” doesn’t have a one-size-fits-all answer due to variations in health plans, assistance programs, dosing schedules, and individual circumstances. However:

The average insured patient typically pays between $5 and several hundred dollars per dose after factoring in copays/coinsurance and assistance programs.

This wide range reflects differences across commercial plans versus government programs like Medicare Part D as well as whether manufacturer savings cards are used effectively.

Your best bet is consulting directly with your insurer’s pharmacy benefits department combined with discussions with your healthcare provider about available financial resources tailored specifically for you.

Key Takeaways: How Much Is Skyrizi With Insurance?

Cost varies based on insurance coverage and plan details.

Copay assistance programs may reduce out-of-pocket expenses.

Prior authorization is often required by insurance providers.

Manufacturer coupons can help lower monthly costs.

Consult your healthcare provider for personalized cost info.

Frequently Asked Questions

How much is Skyrizi with insurance coverage?

The cost of Skyrizi with insurance varies depending on your specific plan. Typically, patients pay a copay or coinsurance after meeting their deductible, which can range from $30 to $150 per dose for commercial insurance holders.

Medicare Part D and other plans may have different cost-sharing structures, so it’s important to check your insurance details.

Does insurance fully cover the price of Skyrizi?

Insurance rarely covers the full list price of Skyrizi, which is between $5,000 and $6,000 per dose. Most plans require copayments or coinsurance, meaning patients still pay a portion of the cost out-of-pocket.

Coverage levels depend on your insurer’s formulary placement and plan design.

What factors influence how much Skyrizi costs with insurance?

Several factors affect your out-of-pocket costs, including your type of insurance plan, deductible status, copay or coinsurance amounts, and whether prior authorization is required.

Each of these can significantly alter what you pay at the pharmacy counter.

How does prior authorization affect the cost of Skyrizi with insurance?

Prior authorization is often required before insurance approves Skyrizi coverage. This process can delay treatment but does not directly increase costs; however, approval is necessary for your insurer to cover part of the medication’s price.

Your healthcare provider must submit documentation to meet these requirements.

Are there assistance programs that reduce Skyrizi costs with insurance?

Yes, many manufacturers and nonprofit organizations offer assistance programs that can lower out-of-pocket expenses for insured patients. These programs work alongside your insurance to help make Skyrizi more affordable.

Check with your healthcare provider or insurer for available options.